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Introduction {#sec1}
============

During cell division, the genome undergoes substantial spatial reorganization to allow for its faithful segregation into the newly formed daughter cells. Mitotic chromosome condensation requires the highly conserved condensin complex ([@bib18], [@bib40], [@bib44]). Condensin is an SMC (structural maintenance of chromosomes) protein complex with a ring-shaped structure that at its heart has a heterodimer of SMC2 and SMC4 proteins. Together, these proteins form a composite ABC (ATP-binding cassette)-like ATPase ([@bib17], [@bib47]). This heterodimer assembles into holocomplexes with three non-SMC subunits. One of these is a member of the kleisin protein family, which together with the SMCs, forms a tri-partite ring. The other two subunits are HEAT-repeat proteins ([@bib13], [@bib31]). Condensin can topologically entrap DNA inside its ring and harbors a second DNA binding interface at one of its HEAT-repeat subunits ([@bib5], [@bib26]).

Metazoans express two distinct complexes, named condensin I and condensin II ([@bib19], [@bib35]). The two complexes share the same SMC dimer, but each binds unique kleisin and HEAT-repeat subunits ([Figure 1](#fig1){ref-type="fig"}A). The complexes also differ in their cellular localization, abundance, and residence time on chromatin. Condensin II is always nuclear, whereas condensin I is cytoplasmic during most of the cell cycle and only gains access to chromosomes upon nuclear envelope breakdown (NEBD) ([@bib16]). During mitosis, condensin II binds to chromosomes with a longer residence time than condensin I, but the former complex is less abundant on mitotic chromosomes than the latter ([@bib9], [@bib50]). In addition to their key role in chromosome condensation, both condensin complexes also regulate sister chromatid resolution ([@bib36], [@bib39]).Figure 1Asymmetric Roles for Condensin's ATPase Sites in Chromosome Condensation(A) Schematic depiction of metazoan condensin complexes.(B) Structural model of the SMC2-SMC4 heterodimer. The ATPase head domains of the two proteins engage by sandwiching two ATP molecules (shown in yellow). This yields two composite ATPase sites, which we call ATPase site 1 and 2 (AS1 and AS2, respectively). The model is based on crystal structures of cohesin's Smc1 (PDB: [1W1W](pdb:1W1W){#intref0085}) and Smc3 (PDB: [4UX3](pdb:4UX3){#intref0090}) subunits. SMC2 is shown in purple and SMC4 in orange. The SMC2 L1085 and SMC4 L1191 residues are highlighted in green.(C) Representative examples of chromosome spreads of wild-type, AS1^*LV*^, and AS2^*LV*^ mutant cells.(D) Percentage of mitotic spreads with fuzzy chromosomes of cells shown in (C). The plot shows mean ± SD of three independent experiments of at least 100 spreads per experiment.(E) Chromosome length measurements of wild-type and AS2^*LV*^ mutant cells. Chromosomes I, II, and III were measured as in the schematic example. The inset depicts a histogram of the length distribution. The plot shows the mean ± SD of three independent experiments of at least 180 chromosomes per experiment.

Recent *in vitro* work shows that condensin can create and enlarge DNA loops through a mechanism known as loop extrusion ([@bib8]). Condensin exerts this key activity in an ATP-dependent manner. The related cohesin complex and bacterial SMC complexes are also thought to act through this mechanism, which somehow involves the ATPase activity of these complexes ([@bib12], [@bib49], [@bib52], [@bib53]). Loop extrusion therefore likely reflects the universal mechanism by which SMC complexes structure genomes in all species ([@bib14], [@bib48]).

How SMC complexes use their ATPase machinery to form DNA loops and structure chromosomes is an important unanswered question. Like all SMC complexes, condensin harbors two ATPase sites ([@bib17]). Each of the two sites sandwiches an ATP molecule between the signature motif of one SMC subunit and the Walker A and Walker B motifs of the other ([@bib21]). Here, we reveal a dual role for condensin's conserved ATPase machinery, in which specifically one ATPase site drives, while the other site rather dampens mitotic chromosome condensation. We find that this asymmetric division of tasks is conserved from yeast to humans. We suggest that this mechanism reflects a universal principle for SMC complexes.

Results {#sec2}
=======

Asymmetric Roles for Condensin's ATPase Sites in Chromosome Condensation {#sec2.1}
------------------------------------------------------------------------

To investigate the role of condensin's ATPase in chromosome condensation, we made use of our recently identified ATPase mutants in the cohesin complex that affect its ATPase cycle, but do support viability ([@bib7]). Because the ATPase machineries of cohesin and condensin are very similar, these residues are also conserved among condensin complexes ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). We thus mutated the endogenous allele of each individual ATPase site of condensin (hereafter referred to as AS1 and AS2) in human HAP1 cells using CRISPR/Cas9 genome-editing technology ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D). These mutations substitute a universally conserved leucine residue of the signature motif of either of condensin's ATPase sites by a valine residue ([Figure 1](#fig1){ref-type="fig"}B). We used guide RNAs that led to cleavage of either the *SMC2* or *SMC4* gene and provided donor oligos that, upon homology-directed repair, introduced the desired mutations and at the same time rendered the genes non-cleavable by the Cas9 nuclease. We hereby successfully obtained viable HAP1 cells with mutant endogenous alleles of *SMC2* (AS1^*LV*^) and of *SMC4* (AS2^*LV*^).

First, we prepared chromosome spreads from wild-type and mutant cells and scored for chromosome condensation. Surprisingly, each mutation led to a very different phenotype. The AS1^*LV*^ mutation resulted in major condensation defects. The chromosomes of these mutant cells were fuzzy and the individual chromosomes were hard to discern ([Figures 1](#fig1){ref-type="fig"}C and 1D). By marked contrast, the AS2^*LV*^ mutation did not lead to condensation defects. Chromosomes from these mutant cells compacted well and were not fuzzy ([Figures 1](#fig1){ref-type="fig"}C and 1D). Upon further examination, we found that AS2^*LV*^ mutant cells in fact harbored chromosomes that are shorter than those found in wild-type cells ([Figure 1](#fig1){ref-type="fig"}E). Importantly, independent mutant clones displayed the same phenotypes ([Figures S1](#mmc1){ref-type="supplementary-material"}E--S1G). The finding that the AS1^*LV*^ mutation leads to hypo-condensation, whereas the AS2^*LV*^ mutation results in hyper-condensation, suggests an asymmetric division of tasks between the two ATPase sites in the condensation process.

Both ATPase Sites Control Condensin Levels on Chromatin {#sec2.2}
-------------------------------------------------------

We then set out to understand how the AS1^*LV*^ and AS2^*LV*^ mutations in condensin lead to these distinct condensation phenotypes. First, we measured the levels of the chromatin-bound fraction of condensin I and II complexes in wild-type and mutant cells ([Figures 2](#fig2){ref-type="fig"}A, 2B, [S2](#mmc1){ref-type="supplementary-material"}A and S2B). Interestingly, both mutations reduced condensin levels on chromatin. In each case, the AS1^*LV*^ mutation had a more pronounced effect than the AS2^*LV*^ mutation. To assess the consequences of merely reduced condensin levels on the condensation process, we knocked out one *SMC2* allele in a diploid background. Although heterozygous deletion led to a reduction in chromatin-bound condensin that was similar to that observed in AS2^*LV*^ cells, it resulted in a condensation defect ([Figures S2](#mmc1){ref-type="supplementary-material"}C--S2F). The hyper-condensation phenotype of the AS2^*LV*^ mutant therefore cannot be explained by simply changing the levels of condensin on mitotic chromosomes.Figure 2Both ATPase Sites Control Condensin Levels on Chromatin(A) Quantitative immunofluorescence of chromatin-bound condensin I in wild-type, AS1^*LV*^ and AS2^*LV*^ mutant cells. Cells were pre-extracted to remove all unbound condensin. Intensity of CAP-H was measured and normalized over CREST signal. Each dot depicts the signal of one cell. Red line indicates the mean ± SEM of at least 50 cells per condition. The graph is representative of one experiment out of at least 3 independent experiments. See [Figure S2](#mmc1){ref-type="supplementary-material"} for condensin II levels.(B) Representative images of mitotic cells stained with CAP-H (green), CREST (cyan), and DAPI (blue) are shown for the cell lines in (A).(C) Fluorescence recovery after photobleaching (FRAP) experiments on wild-type, AS1^*LV*^, and AS2^*LV*^ mutant cells. Cells were transfected with EGFP-CAP-H 48 h before the experiment. The entire fluorescent signal was bleached except for half of the metaphase plate. Recovery in the bleached and unbleached halves of the plate was followed by time-lapse imaging. DNA was visualized using a DNA probe (SiR-DNA). Curves represent difference in fluorescence signal between bleached and unbleached regions after normalization over DNA signal. n = ≥7 cells from at least two independent experiments. Errors bars represent the SEM(D) Representative images before (prebleach), at (bleach), or after bleaching (postbleach) for the cells in (C) are shown with the indicated time in seconds.(E) Live-cell imaging of wild-type, AS1^*LV*^, and AS2^*LV*^ mutant cells. Graph depicts the time spent from nuclear envelope breakdown (NEBD) to alignment and from alignment to anaphase. Cells were labeled with a DNA probe (SiR-DNA) 2 h prior to imaging. The graph shows mean ± SD of three independent experiments with at least 30 cells each.

Because cohesin's release from chromatin is not only dependent on its release factor WAPL, but also on specifically one of cohesin's ATPase sites ([@bib1], [@bib3], [@bib7], [@bib29]), we studied the effects of the AS1^*LV*^ and AS2^*LV*^ mutations on the turnover of condensin I on chromatin by fluorescence recovery after photobleaching (FRAP) experiments ([Figures 2](#fig2){ref-type="fig"}C and 2D). Because condensin II is already stably bound to DNA during early mitosis, we did not test whether the turnover of this complex was affected by the AS2^*LV*^ mutation.

Our FRAP assays fully recapitulated earlier work ([@bib9], [@bib50]), but surprisingly revealed no evident effect of either AS1^*LV*^ or AS2^*LV*^ mutations on condensin I turnover. This result is important for a number of reasons. First, it indicates that the hypo- and hyper-condensation phenotypes are not caused by effects on the residence time of condensin I on chromatin. Second, it suggests that condensin's DNA release reaction is regulated differently than cohesin's. This difference may be related to the absence of a WAPL-like release factor in the case of the condensin complex. Finally, because both mutants affect condensin levels on DNA but neither has an effect on its turnover, this indicates that both ATPase sites contribute to the loading of condensin onto DNA.

Hyper-condensed mitotic chromosomes often are a consequence of prolonged mitosis. We therefore followed wild-type and mutant cells through mitosis in real-time ([Figure 2](#fig2){ref-type="fig"}E). AS1^*LV*^ cells took longer than wild-type to progress from NEBD until chromosome alignment in metaphase, and these cells also spent more time between alignment and anaphase onset. Both delays are presumably a consequence of the condensation defects observed in these cells. AS2^*LV*^ cells, however, progressed through mitosis with normal timing. The observed hyper-condensation effect of the AS2^*LV*^ mutation therefore cannot be explained by differences in mitotic timing.

Condensin's ATPase Has Intrinsic Driver and Dampener Sites {#sec2.3}
----------------------------------------------------------

How then can we explain the opposite condensation phenotypes caused by the AS1^*LV*^ and AS2^*LV*^ mutations? An intriguing possibility would be that the two ATPase sites differentially affect the condensation speed. To directly test this hypothesis, we introduced the AS1^*LV*^ and AS2^*LV*^ mutations into the *Saccharomyces cerevisiae* condensin complex and used the purified complexes to assess how these mutations affect condensin's DNA compaction activity *in vitro*. We measured the rate of DNA compaction by wild-type and mutant yeast condensin using a recently described magnetic tweezers assay ([Figure 3](#fig3){ref-type="fig"}A; [@bib6]).Figure 3Condensin's ATPase Has Intrinsic Driver and Dampener Sites(A) Schematic depiction of *in vitro* condensin-mediated DNA compaction using magnetic tweezers.(B) Representative examples of DNA compaction traces of wild-type, AS1^*LV*^, and AS2^*LV*^. 10 nM condensin and 1 mM ATP were added at t = 0.(C) Average DNA compaction rate for wild-type (n = 27), AS1^*LV*^ (n = 20), and AS2^*LV*^ (n = 26). The plot shows the mean ± SEM. We used the protein preparations depicted in [Figure 4](#fig4){ref-type="fig"}B.

Importantly, this independent *in vitro* system fully recapitulated the *in vivo* results. Complexes harboring the AS1^*LV*^ mutation compacted DNA at a slower rate than wild-type, whereas condensin complexes with the AS2^*LV*^ mutation compacted DNA at twice the speed of wild-type ([Figures 3](#fig3){ref-type="fig"}B and 3C). We confirmed our results using independent protein preparations ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Our results demonstrate that the AS1^*LV*^ and AS2^*LV*^ mutations reciprocally affect condensin's ability to compact DNA, both *in vivo* in human cells and *in vitro* using the budding yeast complexes. This shows that this asymmetric activity is intrinsic to the condensin complex, and also that this function seems to be conserved from yeast to humans. We have hereby identified an unanticipated dual role of condensin's ATPase. AS1 drives mitotic chromosome condensation, while AS2 apparently acts as a dampener whose inactivation results in faster DNA compaction.

ATP Hydrolysis Is Not Rate-Limiting for Loop Enlargement {#sec2.4}
--------------------------------------------------------

Recent work shows that condensin can processively enlarge loops in an ATP dose-dependent manner ([@bib8]). To investigate whether the opposite phenotypes of the AS1^*LV*^ and AS2^*LV*^ mutation can be attributed to changes in their ATPase activities, we assessed the effects of these mutations on condensin's ATP hydrolysis *in vitro*. To this end, we used the purified budding yeast complexes to perform ATPase assays using thin-layer chromatography and radiolabeled ATP ([Figures 4](#fig4){ref-type="fig"}A and 4B). Consistent with previous work, wild-type condensin efficiently hydrolyzed ATP, which was further stimulated by the addition of DNA ([@bib45]). The AS1^*LV*^ and AS2^*LV*^ mutations affected hydrolysis to different degrees. Whereas AS1^*LV*^ mutation reduced both the basic and the DNA-stimulated ATPase activity to about half of that of the wild-type complex, the AS2^*LV*^ mutation had a very subtle effect on the ATPase activity ([Figure 4](#fig4){ref-type="fig"}C). Each ATPase site apparently has a distinct contribution to condensin's ATPase activity. These results suggest that the hypo-condensation phenotype of the AS1^*LV*^ mutant is presumably due to a reduction in ATP hydrolysis rate that is incompatible with proper chromosome condensation. The hyper-condensation phenotype of the AS2^*LV*^ condensin mutant is, however, obviously not due to an increase in ATP turnover rates.Figure 4Condensin's ATPase Site 1 Drives Loop Formation(A) Schematic depiction of the *S. cerevisiae* condensin complex.(B) Coomassie-stained SDS-PAGE of the condensin holocomplex samples as used in (C).(C) ATP hydrolysis rates measured for condensin holocomplexes (5 μM) in the absence or presence of 10 μg/μL of a relaxed 6.4-kb plasmid DNA. The graph shows mean ± SD of five independent experiments for wild-type, AS1^*LV*^ (Smc2 L1048V), and AS2^*LV*^ (Smc4 L1323V) mutants, and three independent experiments for the negative control, the Q-loop mutant AS1^*QL*^ (Smc4 Q302L)-AS2^*QL*^ (Smc2 Q147L).(D) Schematic overview of single-molecule fluorescence assay for condensin-mediated loop extrusion. DNA is double-tethered to a streptavidin-containing surface and stained with Sytox Orange. The addition of 1 nM condensin and 5 mM ATP results in a loop as judged by the local increase in intensity of the fluorescently labeled DNA. DNA loops can be visualized by applying a flow perpendicular to the tethered DNA molecule.(E) Rate of DNA loop extrusion by wild-type (n = 27), AS1^*LV*^ (n = 51), and AS2^*LV*^ (n = 51) condensin. Each circle represents one DNA molecule. Red line depicts the mean. Only DNA molecules with an extension of \<0.65 were included in this graph (for extrusion rates of other DNA extensions check [Figure S4](#mmc1){ref-type="supplementary-material"}A). The experiment was performed using 1 nM condensin and 5 mM ATP.(F) Fraction of DNA molecules that shows a loop using wild-type (n = 109), AS1^*LV*^ (n = 237), or AS2^*LV*^ (n = 124) condensin complexes. The experiment was performed using 1 nM condensin and 5 mM ATP. The graph shows the mean ± 95% confidence interval. Statistical significance was measured using unpaired two-tailed Student's t test, ^∗∗∗∗^p value \< 0.0001. ns, non-significant.

To gain detailed insight into how the two ATPase mutants affect DNA loop extrusion, we used a recently developed single-molecule assay ([@bib8]). This method entails the imaging of a double-stranded DNA that is tethered by its biotinylated ends to a streptavidin-containing surface. The addition of condensin and ATP results in the formation and enlargement of DNA loops that can be visualized by a local and gradual increase in the intensity of the fluorescently labeled DNA ([Figure 4](#fig4){ref-type="fig"}D). We used wild-type, AS1^*LV*^, or AS2^*LV*^ mutant budding yeast condensin complexes at low concentration (1 nM condensin) to examine how the individual complexes form loops. Remarkably, AS1^*LV*^ and AS2^*LV*^ complexes enlarged loops at the same rate as wild-type condensin ([Figures 4](#fig4){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}A). This is a surprise, because the AS1^*LV*^ mutation indeed reduces condensin's ATPase activity by half. Although it is required for loop formation, condensin's ATPase activity thus does not seem to be the rate-limiting step in DNA loop enlargement.

Condensin's ATPase Site 1 Drives Loop Formation {#sec2.5}
-----------------------------------------------

If neither of the ATPase mutants affects DNA loop extrusion rates, then how do these mutants affect the chromosome condensation process? To address whether the AS1^*LV*^ and AS2^*LV*^ mutations might be affecting an early step in the process of DNA looping, we measured the fraction of all tethered DNA molecules that displayed a loop. Interestingly, the fraction of DNA that contained at least one loop was strongly reduced in the presence of the AS1^*LV*^ mutant condensin complexes, whereas the fraction of DNAs with one loop was similar to the wild-type for the AS2^*LV*^ mutant ([Figures 4](#fig4){ref-type="fig"}F, [S4](#mmc1){ref-type="supplementary-material"}A, and S4C). The probability of forming more than one loop on the same DNA molecule was likewise decreased for the AS1^*LV*^ mutant complexes but was again unaffected by the AS2^*LV*^ mutation ([Figure S4](#mmc1){ref-type="supplementary-material"}B). These results indicate that the activity of condensin's AS1 plays a vital role in an early step of the loop formation process, but has little effect on the speed of extrusion once a loop has formed. Because condensin has been suggested to depend on its ATPase activity to transit from an unstable, salt-sensitive to a stable, salt-resistant DNA binding mode ([@bib6]), it is reasonable to propose that the activity of condensin's AS1 site promotes the topological entrapment of DNA.

Condensin's ATPase Site 2 Promotes the Formation of Higher-Order Z Loop Structures {#sec2.6}
----------------------------------------------------------------------------------

The AS2^*LV*^ mutation apparently does not affect condensin's ability to initiate loops, nor does it alter the speed by which it enlarges these loops. How then can we explain that this mutant compacts DNA faster than wild-type not only *in vivo*, but also in the *in vitro* magnetic tweezers set-up? One major difference between the magnetic tweezers and the single-molecule assays is that the former are performed in the presence of a 10-fold higher condensin concentration (10 nM) than the latter (1 nM), where the higher concentration may better mimic the physiological concentration of cellular condensin ([@bib20], [@bib51]). Although it has been shown that a single condensin can form a DNA loop *in vitro*, higher condensin concentrations may favor the cooperative action of multiple condensin complexes.

We therefore repeated the single-molecule fluorescence-imaging assay using 10 nM wild-type condensin. Intriguingly, we observed that the majority of DNA molecules did not exhibit a single loop, but instead displayed a distinct type of higher-order DNA structure characteristic of a conformation of three DNA strands that were stretched along the DNA and hence result in a broad DNA fluorescence signal ([Figure 5](#fig5){ref-type="fig"}A). The detailed analysis of how these "Z loop" structures are formed will be part of a separate study ([@bib24]). To investigate the effect of the AS2^*LV*^ mutant on these higher-order Z loop structures, we scored their abundance for wild-type and AS2^*LV*^ mutant complexes. Interestingly, we found considerably fewer (∼3 times) higher-order Z loops for the AS2^*LV*^ mutant ([Figures 5](#fig5){ref-type="fig"}B).Figure 5Condensin's ATPase Site 2 Promotes Higher-Order Z Loop Structures(A) Representative examples of DNA molecules that show separate loops (left) or a higher-order Z loop structure (right). Dotted circles depict tethered ends of the DNA. Above is a schematic for two separate loops (left) or a formed higher-order Z loop structure on one DNA molecule (right). Red circles represent condensin.(B) Fraction of DNA molecules with higher-order Z loop structures formed by wild-type (n = 189) and AS2^*LV*^ (n = 199) complexes. The experiment was performed as in [Figure 4](#fig4){ref-type="fig"}E, but using 10 nM condensin instead of 1 nM. The graph shows the mean ± 95% confidence interval. Statistical significance was measured using unpaired two-tailed Student's t test, ^∗∗∗∗^p value \< 0.0001.(C) Number of disruption events per DNA molecule for separate loops and higher-order Z loop structures formed by wild-type and AS2^*LV*^ complexes during the course of imaging (10 min). The plots show the mean ± SD. Statistical significance was measured using unpaired two-tailed Student's t test, ^∗∗^p value \< 0.0017.(D) A model depicting the dual role of condensin's ATPase in chromosome condensation. Condensin's ATPase machinery contains two ATPase sites. We propose that these two sites have distinct roles in chromosome condensation. AS1 drives condensation by promoting DNA loop formation. AS2 is involved in the formation of less-productive but more stable higher-order Z loop structures. The balanced activity of AS1 and AS2 is key to chromosome condensation.

We then assessed the stability of higher-order Z loops and found that the disruption of these structures was not affected by the AS2^*LV*^ mutation. We did note, however, that Z loops in general were significantly (∼5 times) more stable once they had formed compared to separate DNA loops ([Figure 5](#fig5){ref-type="fig"}C). Condensin thus can form two types of DNA structures: separate DNA loops that are processively enlarged by a single condensin and more stable higher-order Z loops formed by multiple condensins. Importantly, condensin's ATPase site 2 turns out to promote the formation of these higher-order Z loop structures ([Figure 5](#fig5){ref-type="fig"}D).

Condensin's ATPase Site 2 Limits Chromatin Loop Length {#sec2.7}
------------------------------------------------------

The hyper-condensation phenotype observed with the AS2^*LV*^ mutant could potentially be explained by its relative inability to form higher-order Z loop structures. Processively enlarging loops may indeed condense DNA in a more productive fashion. If the AS2^*LV*^ mutation does cause hyper-condensation through the favored formation of processively enlarging separate loops, then the average loop length should be longer. To assess loop length, we performed chromosome conformation capture (Hi-C) experiments on mitotic cells. To this end, wild-type or AS2^*LV*^ mutant mitotic cells were collected by shake-off after a brief treatment with the microtubule poison nocodazole. These cells were crosslinked with formaldehyde, stained with a mitosis-specific antibody, and then isolated by fluorescence-activated cell sorting (FACS). This protocol resulted in a pure population of mitotic cells that was then processed for Hi-C ([Figure S5](#mmc1){ref-type="supplementary-material"}).

Wild-type cells, in correspondence with earlier work ([@bib32]), yielded a Hi-C map with homogeneous interactions along the whole lengths of chromosomes. This uniform interaction pattern consisted of a band enriched for *cis-*contacts up to distances of ∼12 Mb away from the main diagonal ([Figures 6](#fig6){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}A). AS2^*LV*^ mutant cells instead displayed a band of *cis*-contacts that increased to ∼25 Mb ([Figures 6](#fig6){ref-type="fig"}A, 6B, and [S6](#mmc1){ref-type="supplementary-material"}A). This increase in contact length would be in correspondence with the formation of larger chromatin loops by hyperactive AS2^*LV*^ condensin. Together, these results would therefore support the model that hyperactive AS2^*LV*^ condensin results in shorter chromosomes by favoring the formation of these more productive loops.Figure 6Hyper-Active Condensin I Shortens Mitotic Chromosomes in the Total Absence of Condensin II(A) Whole-chromosome Hi-C matrices of mitotic cells. Cells were harvested by mitotic shake-off after 1.5 h nocodazole treatment. The harvested cells were further selected for their mitotic status by FACS for phospho-MPM2 positivity (see [Figure S5](#mmc1){ref-type="supplementary-material"} for details). Chromosome 10 is shown at 1 Mb resolution. Arrows depict the distance of contacts in wild-type (up to ∼12 Mb) and in AS2^*LV*^ mutant cells (up to ∼25 Mb).(B) Differential Hi-C signal between the indicated cell lines.(C) Whole-chromosome Hi-C matrices of mitotic cells of the indicated cell lines. Cells were prepared as in (A).(D) Differential Hi-C signal between the indicated cell lines.(E) Representative examples of chromosome spreads of the indicated cell lines. At least 120 spreads were examined in three independent experiments.(F) Schematic depiction of mitotic chromosome structure in the indicated genotypes. Condensin I complexes are depicted as blue circles and condensin II as red circles.

Together, condensin's AS2 could thus act as a dampener of chromosome condensation by promoting the formation of less-productive higher-order Z loop structures, which limit the degree to which chromatin loops can be enlarged. Provided that there is enough DNA between the individual condensin complexes to keep extruding, a preference for productive separate loops could well lead to hyper-condensed chromosomes. Notably, the AS2^*LV*^ mutation also reduces condensin levels on chromatin, which provides the necessary space between adjacent condensin complexes for further reeling of DNA that ultimately results in greater loop enlargement.

Hyperactive Condensin I Shortens Chromosomes in the Total Absence of Condensin II {#sec2.8}
---------------------------------------------------------------------------------

Metazoans express two distinct condensin complexes. The difference in the localization, stability, and levels on chromatin between condensin I and condensin II hints at specific roles for each of the two complexes. Moreover, whereas condensin I is key to lateral chromosome compaction, condensin II is thought to be specifically required for the shortening of chromosomes ([@bib11], [@bib42]). Recent super-resolution imaging and Hi-C experiments on mitotic chromosomes suggest that these two complexes shape mitotic chromosomes by forming loops with different sizes ([@bib10], [@bib50]). These studies propose that condensin II is required to build long chromatin loops, while condensin I is responsible for the formation of smaller loops within the larger condensin II-mediated loops.

Because condensin I and II share the same SMC subunits, the AS1^*LV*^ and AS2^*LV*^ mutations affect both complexes ([Figure 1](#fig1){ref-type="fig"}A). Our ability to hyper-activate condensin I with the AS2^*LV*^ mutation allowed us to test whether condensin II has an irreplaceable role in structuring mitotic chromosomes. We first knocked out the condensin II-specific subunit CAP-H2 in HAP1 cells using CRISPR/Cas9 ([Figure S6](#mmc1){ref-type="supplementary-material"}B). As expected, *ΔCAP-H2* cells displayed condensation defects that ranged in severity from cells with long and zig-zag shaped chromosomes to others with an indiscernible fuzzy chromatin mass ([Figures 6](#fig6){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}C). *ΔCAPH-2* cells also exhibited chromosome segregation errors and were delayed in mitosis ([Figures 7](#fig7){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}D). We then examined which *ΔCAP-H2* defects can or cannot be rescued by hyper-activating condensin I with the AS2^*LV*^ mutation. We therefore introduced this mutation into *ΔCAP-H2* HAP1 cells ([Figure S7](#mmc1){ref-type="supplementary-material"}A). It is worth noting that we were unable to obtain cells with the AS1^*LV*^ mutation in a *ΔCAP-H2* background. Because each individual mutation results in condensation and segregation defects, this specific combination presumably is synthetic lethal ([Figures S7](#mmc1){ref-type="supplementary-material"}B and S7D).Figure 7Condensin II Specifically Prevents the Formation of Ultrafine Bridges(A) Quantification of segregation errors that occur during anaphase for the indicated cell lines. The plot shows the mean ± SD of three independent experiments, with at least 50 anaphases per experiment.(B) Representative anaphases with either normal segregation or a missegregation as quantified in (A). DNA was visualized by immunofluorescence with DAPI staining (blue), phosphorylated histone H3 (pH3) (green), and centromeres were visualized by CREST (cyan).(C) Quantification of ultrafine bridges (UFBs), as visualized by PICH staining, in late anaphase cells (anaphase B). The plot shows the mean ± SD of three independent experiments, with at least 50 anaphases per experiment. See [Figure S7](#mmc1){ref-type="supplementary-material"}G to compare to UFBs of early anaphase cells (anaphase A).(D) Representative anaphases with normal segregation or an ultrafine bridge (UFB) as quantified in (C). DNA was visualized by immunofluorescence with DAPI staining (blue), UFBs by PICH staining (red), and centromeres were visualized by CREST (cyan).(E) Schematic model of the specific roles of condensin I and II in structuring chromosomes. Both condensin II and hyperactive condensin I (condensin I AS2^*LV*^) can shorten mitotic chromosomes. Only condensin II plays a specific role in the decatenation of entangled DNAs from S phase onward. Cohesin complexes connecting the sister chromatids are depicted in green.

Interestingly, chromosomes of *ΔCAP-H2* cells expressing the hyper-activating AS2^*LV*^ mutant condensed their chromosomes into structures that were generally even shorter than wild-type chromosomes ([Figure 6](#fig6){ref-type="fig"}E). The hyper-activating AS2^*LV*^ mutation also rescued the high percentage of fuzzy chromosomes caused by condensin II deficiency ([Figure S7](#mmc1){ref-type="supplementary-material"}B). Notably, condensin I turnover was affected neither by condensin II deficiency nor by the AS2^*LV*^ mutation ([Figure S7](#mmc1){ref-type="supplementary-material"}C). Stably chromosome-bound condensin II, therefore, is neither inherently required for efficient condensation nor for the shortening of chromosomes in particular. However, upon closer examination of the hyper-condensed chromosomes, we noticed that chromosomes of *ΔCAP-H2* cells harboring the hyper-activating AS2^*LV*^ mutant appeared less straight than those of AS2^*LV*^ single mutant cells ([Figures 6](#fig6){ref-type="fig"}E and 6F).

We then compared the Hi-C profiles of *ΔCAP-H2* cells and *ΔCAP-H2* cells with the AS2^*LV*^ mutation. *ΔCAP-H2* cells lost their long-range interactions when compared to wild-type cells, in correspondence with a requirement for condensin II in forming large DNA loops ([Figure S6](#mmc1){ref-type="supplementary-material"}E). The *ΔCAP-H2* cells with the AS2^*LV*^ mutation did not regain the long-range contacts in the 12--25 Mb range ([Figure 6](#fig6){ref-type="fig"}C). How then can the AS2^*LV*^ mutant yield hyper-condensed chromosomes both in wild-type and in *ΔCAP-H2* cells, if their interaction maps are so different? To address this question, we plotted the difference in interactions between the respective genotypes ([Figure 6](#fig6){ref-type="fig"}D). We found that the AS2^*LV*^ mutant in *ΔCAP-H2* cells in fact did display an increase in longer-range contacts that shifted from very short-range contacts close to the diagonal of the Hi-C map to contacts of up to ∼5 Mb distances. This suggests that condensin I when hyper-activated generates extended loops that are sufficient to shorten mitotic chromosomes.

Taken together, condensin I and II each form loops with specific ranges in size. Condensin II forms long loops, while condensin I forms smaller loops. Hyper-activation of either of these complexes by the AS2^*LV*^ mutation appears to yield extended loops within the size-range of the respective complex. Even though the AS2^*LV*^ mutant yields hyper-condensed chromosomes both in wild-type and in *ΔCAP-H2* cells and chromosomes superficially look similar, condensin II does have a specific role in the organization of these chromosomes. We propose that the formation of condensin II-specific long loops is required for a straight chromosomal axis ([Figure 6](#fig6){ref-type="fig"}F).

Condensin II Specifically Prevents the Formation of Ultrafine Bridges {#sec2.9}
---------------------------------------------------------------------

Proper condensation is a prerequisite for faithful chromosome segregation ([@bib9], [@bib30]). Consistently, *ΔCAP-H2* cells suffer from an increase in chromosome segregation errors compared to wild-type cells ([Figures 7](#fig7){ref-type="fig"}A and 7B). In correspondence with the rescue of the major condensation defect, the hyper-activating AS2^*LV*^ mutant also largely rescued this segregation defect ([Figures 7](#fig7){ref-type="fig"}A and 7B). AS2^*LV*^ mutant cells and *ΔCAPH2* cells harboring AS2^*LV*^ both displayed the same degree of basic segregation errors. However, neither of these genotypes displayed wild-type like segregation fidelity. This indicates that hyper-condensation may not be beneficial for faithful chromosome segregation.

Mitoses of *ΔCAP-H2* cells also displayed an increase in ultrafine bridges ([Figures 7](#fig7){ref-type="fig"}C, 7D, and [S7](#mmc1){ref-type="supplementary-material"}F--S7H). This is interesting, because condensin II is nuclear throughout the cell cycle and plays a role in the resolution of sister chromatids from S phase onward ([@bib36], [@bib39]). This resolution could, for example, aid the disentangling or decatenation of sister DNAs. The persistence of such catenanes can lead to ultrafine DNA bridges during mitosis. Condensin I only contacts DNA upon nuclear envelope breakdown (NEBD). Importantly, we find that hyperactive condensin I cannot rescue the increase in ultrafine bridges observed in *ΔCAP-H2* cells. Together, this would support the model that hyperactive condensin I by itself can condense chromosomes within the relatively short window spanning the time from NEBD to metaphase, but that the decatenation of entangled DNAs requires more time and therefore needs the presence of condensin II from S phase onward ([Figure 7](#fig7){ref-type="fig"}E).

Discussion {#sec3}
==========

Condensin's Two ATPase Sites Play Distinct Roles {#sec3.1}
------------------------------------------------

How condensin's ATPase drives mitotic chromosome condensation is a major question of chromosome biology. We here identify an unexpected dual role for this machinery that is conserved from yeast to humans. Specifically one of condensin's ATPase sites (AS1) drives loop formation, while the other ATPase site (AS2) promotes the formation of higher-order Z loop structures ([Figure 5](#fig5){ref-type="fig"}D). Because SMC complexes organize genomes from bacteria to humans, we suggest that such an asymmetric division of tasks may reflect a universal principle for these molecular motors.

Cohesin's ATPase machinery also harbors an asymmetric activity, which is evident from the fact that only one of cohesin's ATPase sites is required for cohesin release from DNA. Our FRAP experiments, however, indicate that the analogous ATPase site in condensin (AS2) does not play such a role. This might well be related to the fact that condensin has no dedicated WAPL-like release factor. How condensin in fact releases DNA remains unclear. It is striking though that the analogous site in both cases has a function that is antagonistic to the overall function of the complex. For condensin, this site has a dampening function, while for cohesin it is required for the release of this complex from chromatin. Condensin's HEAT-repeat subunits have contrasting functions in condensation ([@bib25], [@bib28]). Whether these opposing functions are linked to the ATPase machinery is yet unknown. Each of these proteins binds to a different part of condensin's kleisin subunit ([@bib34], [@bib38]). Moreover, recent work on the *E. coli* SMC complex, MukBEF, indicates that the individual ATPase sites can be regulated independently through binding to different parts of the kleisin ([@bib54]).

Recent single-molecule experiments have shown that condensin is a molecular motor that can processively enlarge loops in an ATP-dependent manner ([@bib8]). ATP hydrolysis is required both for condensin's stable, salt-resistant DNA binding and for subsequent compaction of DNA ([@bib6], [@bib43]). Hydrolysis-deficient condensin complexes were previously found to localize to chromatin ([@bib23], [@bib25], [@bib37], [@bib46]), but considering the available *in vitro* data, these complexes presumably were not stably bound to DNA. This is in line with experiments using these classical "Walker B" mutant forms of the cohesin complex ([@bib22], [@bib27]). Intriguingly, the AS1^*LV*^ and AS2^*LV*^ mutants are partially impaired in their ATPase activity, but they do bind DNA with wild-type like stability *in vivo* as judged by FRAP. The analogous mutations in the cohesin complex are proficient in ATP binding and ADP release, and display reduced ATP hydrolysis ([@bib7]). Reduced ATP hydrolysis is unlikely to be the explanation of the hyper-condensation phenotype observed for the AS2^*LV*^ mutant. We therefore suggest that this signature motif mutation affects a key conformational change in the complex that would normally limit the degree of condensation. The partial inactivation of condensin's ATPase cycle has allowed us to investigate the roles of the different ATPase sites post condensin loading. We propose that both sites are involved in loading, but that specifically AS1 is important for the condensation process itself, which in turn is dampened by AS2.

AS1 and AS2: The Engine's Start and Stop Buttons {#sec3.2}
------------------------------------------------

We find that the ATPase activity of condensin is surprisingly not rate-limiting for the loop enlargement process itself. Despite reduced ATP hydrolysis, the AS1^*LV*^ mutant does not affect the speed of loop enlargement, but rather impairs loop formation. This is in accordance with recent findings in *B. subtilis* that impairing the ATPase activity of the SMC complex in this species delays loop formation ([@bib53]). Interestingly, a very recent study shows that ATP binding by the Smc2 and Smc4 ATPase heads has distinct consequences for the architecture of the condensin complex. Whereas the latter can initiate ATP binding in the absence of its partner, the nucleotide binding by the former can only take place once the head heterodimer has been formed ([@bib15]). This result would be in agreement with our finding that specifically AS1 initiates condensation. How does the driver ATPase site (AS1) then control this step of loop formation? We suggest that AS1 either promotes the entrapment of a second DNA element within condensin's lumen to form an initial tiny loop, or that it kick-starts the loop enlargement process. Both these steps are likely to require a drastic conformational change in the complex's structure that could involve specifically this ATPase site.

Mutation of AS2 results in hyper-condensation without affecting mitotic timing, condensin's turnover on chromatin, or increasing ATP hydrolysis rates. Instead, mutating this site drastically diminishes the formation of higher-order Z loop structures. How could this then lead to the hyper-condensation phenotype? We suggest that this could be related to a fundamental difference between separate loops and Z loops. Two condensin complexes that are each forming a separate loop can in essence keep processively enlarging their loops, provided that they encounter no obstacles. Two condensin complexes that together form a Z loop can, however, only shorten a given DNA segment up to a maximum of 3-fold ([@bib24]). A preference of the AS2^*LV*^ mutant for separate loops over Z loops could therefore lead to shorter, hyper-condensed, chromosomes.

But why would wild-type condensin actually form such Z loops if this limits the degree of condensation? Would it not be beneficial for cells to be able to condense DNA more efficiently? One possibility is that cells may want to restrict the length of chromatin loops. This could, for example, prevent DNA entanglements between sister chromatids. This model is supported by our finding that AS2^*LV*^ mutant cells, which harbor longer DNA loops, also show an increase in chromatin bridges. By preventing the formation of long loops, AS2 would hereby ensure faithful chromosome segregation. AS2-dependent higher-order Z loops could also serve to stabilize chromatin loops. In line with this possibility, these structures indeed are more stable than separate loops.

Condensin I versus Condensin II {#sec3.3}
-------------------------------

Metazoans have two distinct condensin complexes that differ in their protein composition, cellular localization, abundance, and stability on DNA. We find that condensin II-deficient cells have long and fuzzy chromosomes, but that hyperactive condensin I can efficiently shorten chromosomes even in the total absence of condensin II. This is surprising, because condensin II is thought to have a specific role in the shortening of mitotic chromosomes ([@bib42]). We propose that the time from NEBD to anaphase is not sufficient for wild-type condensin I to condense chromosomes without the help of condensin II, but condensin II does not have an irreplaceable function in this process.

We find that condensin II does have at least two key roles that cannot be compensated for by hyper-active condensin I. The first is that condensin II has a specific role in the formation of longer-range *cis* contacts than does condensin I. Considering these findings and the timing at which the two complexes contact DNA, our data would support the hypothesis that condensin II initiates condensation by forming long loops and that, upon NEBD, condensin I makes small loops within these larger loops ([Figure S7](#mmc1){ref-type="supplementary-material"}I). This is also consistent with earlier work showing that condensin I is important for reducing the width of chromosomes ([@bib42]). Condensin II in a normal setting would then be important for the shortening of chromosomes, but we find that this role can be taken over by hyperactive condensin I.

A recent study proposed that condensin II plays a role in the formation of a helical turn within the axis of mitotic chromosomes and that the megabase-scale contacts measured in these experiments reflect interactions between loops that are stacked in a helical fashion ([@bib10]). We find that mitotic chromosomes can efficiently be shortened without such a condensin II-dependent helical axis. Notably, these shortened chromosomes are morphologically distinct because they appear less straight. The condensin II-specific long loops therefore might be important for the formation of straight chromosomes.

We suggest that specifically condensin II plays a key role in the decatenation of sister chromatids. The nuclear localization of condensin II may allow this complex to aid decatenation from S phase onward. Even though hyperactive condensin I is sufficient for the condensation process per se within the limited time window from NEBD to anaphase, the decatenation process may well require considerably more time and might mostly take place during interphase. Condensin I can in fact regulate DNA catenation, because its inactivation in *Drosophila* cells during metaphase results in an increase in catenanes ([@bib39]). We therefore expect that condensin II's contribution to decatenation simply is a consequence of the spatiotemporal regulation of this complex.

Hyper-activation of both condensin I and condensin II leads to hyper-condensed chromosomes, but interestingly this also causes an increase in chromosome segregation errors. This indicates that condensin's ability to condense chromosomes needs dampening to ensure faithful chromosome segregation. The balanced activity of the two ATPase sites indeed appears to be key to both the condensation and the segregation of chromosomes. We propose that asymmetric ATPases with distinct roles for each ATPase site reflect a universal principle that enables the ancient family of SMC protein complexes to intricately control chromosome architecture.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**CAP-HNovus BiologicalsCat\# NBP1-32573CAP-H2 (Immunofluorescence)[@bib33]N/APICHAbnovaCAT\# H9181CRESTCortex BiochemistryCAT\# CS1058MPM2MilliporeCAT\# CV-05-368SMC4BethylCAT\# A300-064aCAP-H2 (Western blot)BethylCAT\# A302-275aGoat anti-Rabbit-PODAKOCat\# P0448Goat anti-Mouse-PODAKOCat\# P0447Goat anti-Mouse-488Molecular probesCat\# A11029Goat anti-Rabbit-488Molecular probesCat \# A32731Histone H3 phospho S10AbcamCat\# ab5176**Bacterial and Virus Strains**Competent cells, Alpha-Select Gold EfficiencyGC BiotechBIO-85027**Chemicals, Peptides, and Recombinant Proteins**Blasticidin SInvitrogenCat\# R210-101PuromycinSigma-AldrichCat\# P7255DAPISigma-AldrichCat\# D9542SiR-DNASpicrochromeCAT\# SC007VectashieldVector LaboratoriesCat\# H-1000Sytox OrangeThermoFisherCat\# S11368StreptavidinThermoFisherCat\# 11406452BSAThermoFisherCat\# 10536735Biotin-PEGLaysan BioCat\# Biotin-PEG-SVA-5000-1gPEGLaysan BioCat\# MPEG-SVA-5000-1gGlucose OxidaseThermoFisherCat\# 11491092CatalaseSigma-AldrichCat\# C30Lambda DNAPromegaCat\# D1521ATPThermoFisherCat\# R0441S. cerevisiae/ condensin holocomplex (wild type)[@bib45]N/AS. cerevisiae/ condensin holocomplex (Smc2 L1048V)This paperN/AS. cerevisiae/ condensin holocomplex (Smc4 L1323V)This paperN/AS. cerevisiae/ condensin holocomplex (Smc2 Q147L, Smc4 Q302L)[@bib45]N/AMPS1 InhibitorReagencyCat\# rgncy-00015NocodazoleMP Biomedicals B.V.Cat\# 0215240525**Critical Commercial Assays**HiSeq SR Cluster Kit v4 cBotIlluminaCat\# GD-401-4001**Deposited Data**Hi-CThis paperGEO: [GSE108774](ncbi-geo:GSE108774){#intref0010}Smc1 head structurePDBPDB: [1W1W](pdb:1W1W){#intref0015}Smc3 head structurePDBPDB: [4UX3](pdb:4UX3){#intref0020}**Experimental Models: Cell Lines**HAP1[@bib4]N/AHAP1 *ΔCAP-H2*This paperN/AHAP1 AS1^*LV*^This paperN/AHAP1 AS2^*LV*^This paperN/AHAP1 *ΔCAP-H2*/AS2^*LV*^This paperN/AHAP1 SMC2^*WT/Δ*^This paperN/A**Oligonucleotides**SMC2 gRNA Forward: CACCGCTGAACTTAGTGGTGGTCAGThis paperN/ASMC2 gRNA Reverse: AAACCTGACCACCACTAAGTTCAGCThis paperN/ASMC4 gRNA Forward: CACCGAAGATCTTCAACCTTTCGGGThis paperN/ASMC4 gRNA Reverse: AAACCCCGAAAGGTTGAAGATCTTCThis paperN/ASMC2 L1085V repair oligo: CAAGGTTGCCTTGGGAAA\
TACCTGGAAAGAAAACCTAACTGAAGTTAGTGGTGGT\
CAGAGGTGAGGAATCACTTTGCTATATTATAATTTThis paperN/ASMC4 L1191V repair oligo: CAGTGTTCGACCACCTAA\
GAAAAGTTGGAAAAAGATCTTCAACGTTTCGGGAGG\
AGAGAAAACACTTAGTTCATTGGCTTTAGTATTTGThis paperN/ACAP-H2 targeting CRISPR Forward: CACCGTTCTT\
GGTGAGGTCGCGGAThis paperN/ACAP-H2 targeting CRISPR Reverse: AAACTCCGCG\
ACCTCACCAAGAACThis paperN/ASMC2^*WT/Δ*^ gRNA Forward: CACCGCTTTTATAGGTGGTTATTGGThis paperN/ASMC2^*WT/Δ*^ gRNA Reverse: AAACCCAATAACCACCTATAAAAGCThis paperN/A**Recombinant DNA**6.4-kb plasmid DNA[@bib5][1288](mi:1288){#intref0025}pX330AddgeneCat\# 42230pDonorBlast[@bib2]N/ApC1-EGFP-CAP-H[@bib9]N/A**Software and Algorithms**LAS-AF FRAP-WizardLeicaN/AFijiImageJ<https://imagej.net/Welcome>PrismGraphPad<https://www.graphpad.com>SoftWorxApplied PrecisionN/ACrispr designZhang Lab<http://zlab.bio/guide-design-resources>HiC-Pro v2.7.7[@bib41]N/AFRAP analysis macroThis paperN/AGENOVA V0.9GitHub<https://github.com/robinweide/GENOVA>

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Benjamin D. Rowland (<b.rowland@nki.nl>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Cell line {#sec4.3.1}

HAP1 cells ([@bib4]) were cultured at 37°C with 5% CO~2~ in IMDM (GIBCO), supplemented with 12% FCS (Clontech), 1% Penicillin/Streptomycin (Invitrogen) and 1% UltraGlutamine (Lonza).

Method Details {#sec4.4}
--------------

### Genome Editing {#sec4.4.1}

To introduce endogenous mutations, CRISPR/Cas9 genome-editing was performed as described ([@bib7]). In brief, guide RNAs (gRNAs) targeting SMC2 and SMC4 were designed using the online CRISPR design tool (<http://zlab.bio/guide-design-resources>). SMC2 gRNA sequences used: Forward CACCGCTGAACTTAGTGGTGGTCAG, Reverse AAACCTGACC ACCACTAAGTTCAGC. SMC4 gRNA sequences used: Forward CACCGAAGATCTTCAA CCTTTCGGG and Reverse AAACCCCGAAAGGTTGAAGATCTTC. Phosphorylated and annealed oligo's were ligated into pX330 (Addgene plasmid \#42230). To introduce the SMC2 L1085V mutation we designed a 90-bp homology-directed donor oligo: for SMC2: CAAGGTTGCCTTGGGAAATACCTGGAAAGAAAACCTAACTGAA[GTT]{.ul}AGTGGTGGTCAGAGGTGAGGAATCACTTTGCTATATTATAATTT. For SMC4 L1191V mutation we used a donor oligo: CAGTGTTCGACCACCTAAGAAAAGTTGGAAAAAGATCTTCAAC[GTT]{.ul}TCGG GAGGAGAGAAAACACTTAGTTCATTGGCTTTAGTATTTG. To obtain *CAP-H2* knockout cells, Forward CACCGTTCTTGGTGAGGTCGCGGA and Reverse AAACTCCGCGACCTCA CCAAGAAC sgRNAs were cloned into px330. HAP1 clones were generated by insertion of a Blasticidine cassette, as previously described ([@bib12]). 0.1 μg pBabe-Puro was co-transfected (1:10 ratio to CRISPRs) to select for transfected cells using FuGENE 6 (Promega) according to the manufacturer's protocol. Puromycin (2 μg/ml, Sigma-Aldrich) was added to select for transfected cells. Genomic DNA was isolated from picked single clones and the desired mutations were scored for by Sanger sequencing. To obtain the SMC2^*WT/Δ*^, diploid HAP1 cells were transfected with sgRNA, Forward: CACCGCTTTTATAGG TGGTTATTGG and Reverse: AAACCCAATAACCACCTATAAAAGC. Heterozygous clones for *SMC2* were identified by Sanger sequencing.

### ATPase Assays {#sec4.4.2}

The five-subunit wild-type, Smc2 L1048V, Smc4 L1323V, Smc2 Q147L and Smc4 Q302L mutant condensin complexes were expressed and purified from budding yeast, and ATP hydrolysis rates of condensin holocomplexes were measured as described ([@bib45]). In short, reactions (10 μl) were prepared with 0.5 μM condensin holocomplex, with or without 24 nM relaxed circular 6.4-kb plasmid DNA in ATPase buffer (40 mM TRIS--HCl pH 7.5, 125 mM NaCl, 10% (v/v) glycerol, 5 mM MgCl~2~, 5 mM ATP, 1 mM DTT and 33 nM \[α^32^P\]-ATP; Hartmann Analytic) and incubated at room temperature (∼25°C). One microliter of the reaction mix was spotted onto PEI cellulose F TLC plates (Merck) every 3 min for a total duration of 15 min. Reaction products were resolved using 0.5 M LiCl and 1 M formic acid solution and analyzed on a Typhoon FLA 9,500 scanner (GE Healthcare). ATP hydrolysis rates were calculated from the ADP/ATP ratios from time points in the linear range of the reaction.

### Structural Model {#sec4.4.3}

The structural model of the ATPase head domains of SMC2-SMC4 heterodimer was generated using the SWISS-MODEL web tool. The model was based on the crystal structures of cohesin's subunits Smc1 (PDB: [1W1W](pdb:1W1W){#intref0060}) and Smc3 (PDB: [4UX3](pdb:4UX3){#intref0065}).

### Immunofluorescence {#sec4.4.4}

Cells were grown on 12 mm glass coverslips and pre-extracted using PEM-T buffer (100mM PIPES pH 6.8, 1 mM MgCl~2~, 5 mM EGTA and 0.2% Triton) for 60 s. Fixation was performed with 4% paraformaldehyde (PFA) for 6 minutes with PEM-T buffer followed by 4 minutes without PFA and blocking was with 3% BSA in PBS for 1 hour. The following antibodies were used: CAP-H (Novus Biologicals), CREST (Cortex Biochem), PICH (Abnova), Histone H3 phospho S10 (Abcam). All antibodies were used at 1:1000 dilution and incubated overnight at 4°C. Secondary antibodies (Molecular probes, Invitrogen) and DAPI were incubated for 1 hour at room temperature. Coverslips were mounted with Vectashield (Vector Laboratories, H-1000). Images were taken using a Deltavision deconvolution microscope (Applied Precision) and image acquisition was done using Softworx (Applied Precision), ImageJ and Photoshop. For the micronuclei assay, HAP1 wild-type cells were treated overnight with 200 nM of an MPS1 inhibitor.

### Magnetic Tweezers {#sec4.4.5}

Real-time condensin-mediated compaction experiments were done with magnetic tweezers as described ([@bib6]). Briefly, a 20kb DNA construct was stretched between a surface and a magnetic bead. All experiments were carried out in 10 mM HEPES-NaOH pH 7.9, 125 mM NaCl, 5mM MgCl~2~, 1mM DTT. A pre-measurement was taken before addition of protein. Then, condensin wild-type or mutant holocomplexes (10 nM) were added together with ATP (1 mM). Tracking of the beads started immediately after addition of the protein and the force was kept constant throughout all experiments (0.75 pN), except in experiment S3B we increased the force to 1.5 pN. The compaction rate was determined as described ([@bib6]).

### Single-Molecule Fluorescence Assay {#sec4.4.6}

The single-molecule fluorescence assay was performed as described ([@bib8]). In brief, lambda DNA was immobilized to a PEG-passivated glass surface via streptavidin-biotin linkage at both its ends. The individually distributed tethered DNA was stained with 500 nM Sytox Orange (SxO), (S11368, Thermofisher) for imagining under a home-built wide-field fluorescence microscope using a 532 nm excitation laser. The process of DNA loop extrusion was monitored upon the addition of condensin (1 or 10 nM according to the experiment) and ATP (5 mM) in condensin buffer (50 mM TRIS-HCl pH 7.5, 50 mM NaCl, 2.5 mM MgCl2, 1 mM DTT) and an oxygen scavenging system. For [Figure S4](#mmc1){ref-type="supplementary-material"}C, the SFM assay was performed with the same salt concentration used in the magnetic tweezer experiment shown in [Figure 3](#fig3){ref-type="fig"} (125 mM NaCl and 5 mM MgCl~2~). To visualize DNA loops, a constant rate of buffer flow was applied during the course of the experiment with an angle nearly perpendicular to the surface to which DNA is attached.

The rate of DNA loop extrusion was estimated as described previously ([@bib8]). Briefly, fluorescence intensity kymographs were built from concatenating the normalized intensity profiles of SxO-stained DNA molecules per time point. From the obtained kymographs, the position of the loop at each time point was found by center-of-mass tracking along the length of DNA molecule. Subsequently, the DNA loop size was calculated by integrating the intensity from 11 pixels cantered at the position of the loop and multiplying it by the length of lambda DNA (48.502 kbp) per time point. Finally, the rate for DNA loop extrusion was determined from the slope of linear DNA size increase observed in the first 10 s of the DNA loop extrusion.

The observed separate loops and higher-order structures as shown in [Figures 4](#fig4){ref-type="fig"}B--4D were well-distinguishable to each other in our experiments. The separate loops were observed as two local maxima along the otherwise homogeneous fluorescence intensity of the DNA molecule, while the higher-order DNA structures appeared as an elongated line of high fluorescence intensity that stretched along the length of DNA. The 'disruption' event of separate loops or higher-order structures shown in [Figure 4](#fig4){ref-type="fig"}C was defined as an event from which their respective characteristic structures are disappeared, namely, a release of one or both of the DNA loops into an initial bare DNA and a release of the elongated structure into a single loop, for separate loops and higher-order structure, respectively. Statistical analysis was performed using GraphPad Prism 8 software. The applied statistical method and *P value*s are reported in the figure legends. Statistical significance is categorized as follows: ^∗∗^p \< 0.01 and ^∗∗∗∗^p \< 0.0001.

### Hi-C {#sec4.4.7}

Cells were plated in T175 flasks (Cellstar, Greiner bio-one). The next day, cells were treated with nocodazole for 1.5 hours and mitotic cells were collected by shake-off. Cells were cross-linked with 2% formaldehyde, blocked with 3% BSA in PBS with Tween 0.1% (PBST) and then incubated with the mitosis-specific antibody MPM2 (1:500, Millipore) overnight at 4°C. Cells were washed with PBST then incubated with the secondary Alexafluor antibody. Labeled mitotic cells were sorted by FACS (BD FASAira II, BD biosciences). 5-10 million sorted cells were treated with 0.1% SDS final concentration (5μl 10% SDS per 500μl volume) and incubated for 10 minutes at 65°C. Then 30μl 20% Triton X-100 (Sigma-Aldrich) was added to the cells (final concentration = 1% Triton X-100). The subsequent sample preparation steps were done as described ([@bib12]). Raw sequence data was mapped and processed using HiC-Pro v2.9 ([@bib41]). Data was mapped to hg19. The relative contact probability was computed as previously described ([@bib12]).

### Chromosome Spreads {#sec4.4.8}

Cells were treated with nocodazole for 1.5 hours and mitotic cells were collected by shake-off. Cells were incubated with 75 mM KCl for 20 minutes. Cell pellets were twice resuspended in fixative solution (Methanol: Acetic Acid, 3:1) and spun down. Fixed cells were incubated with DAPI and dropped on tilted cover slides, and then dried at 37°C. Dried slides were mounted with Vectashield (Vector Laboratories, H-1000). Images of spreads were taken using the Metafer system (Metasystems).

### Live-Cell Imaging {#sec4.4.9}

Cells were grown on 8-well glass-bottom dishes (LabTek). Two hours prior to imaging, SiR-DNA probe (1:2000, Spirochrome) was added together with verapamil (1:10000) to visualize DNA in L-15 CO~2~-independent medium (GIBCO). Images were taken using a Deltavision deconvolution microscope (Applied Precision). Cells were imaged every 5 minutes using a 40x air objective with 3 × 3 μm Z stacks. Image acquisition was carried out using Softworx (Applied Precision) and ImageJ.

### Fluorescence Recovery After Photobleaching (FRAP) Assays {#sec4.4.10}

Cells were transfected with a pC1-EGFP-CAP-H construct in 4-well glass bottom dishes (LabTek). 48 hours post-transfection, SiR-DNA probe (1:2000, Spirochrome) was added to cells to visualize DNA, in L-15 CO~2~-independent medium (GIBCO). FRAP experiments were performed using a confocal microscope (Leica Microsystems) with a 63x oil immersion objective using the LAS-AF FRAP-Wizard. Images were taken by accumulating 4 frames at a scanning speed of 1000 Hz. Photobleaching was performed by 6 times illuminating the selected region at 100-fold laser power (488 nm Laser). 60 post-bleaching images were taken with 10 s intervals. Analysis of images was done using an in-house ImageJ macro. A mask on the DNA signal was created and the EGFP-CAP-H signal was normalized to the DNA signal.

### Western Blotting {#sec4.4.11}

Cells were grown in 6-well plates, harvested and lysed with Laemmli buffer (120 mM Tris pH 6.8, 4% SDS, 20% glycerol) by boiling at 95°C for 5 minutes. Total protein concentration was determined with Lowry assays and protein levels were analyzed with western blotting. The following antibodies were used: SMC4 (1:5000 Bethyl) and CAP-H2 (1:1000, Bethyl).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Statistical details of experiments can be found in the figure legends or [Method Details](#sec4.4){ref-type="sec"} section.

Data and Code Availability {#sec4.6}
--------------------------

Software used for Hi-C data analysis can be found at: <https://github.com/robinweide/GENOVA>.

The accession number for the data for Hi-C reported in this paper is NCBI GEO: [GSE108774](ncbi-geo:GSE108774){#intref0075}.
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